View ValuationAtlas Arteria 将来の成長Future 基準チェック /26Atlas Arteria利益と収益がそれぞれ年間19%と4.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に6.3% 17.2%なると予測されています。主要情報19.0%収益成長率17.17%EPS成長率Infrastructure 収益成長13.0%収益成長率4.9%将来の株主資本利益率6.27%アナリストカバレッジGood最終更新日07 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • May 01High number of new directorsCEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024.お知らせ • Apr 27IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer. The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer. Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited.お知らせ • Mar 17Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026お知らせ • Mar 16Atlas Arteria Limited, Annual General Meeting, May 13, 2026Atlas Arteria Limited, Annual General Meeting, May 13, 2026.Board Change • Dec 24High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 10Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026Reported Earnings • Aug 29First half 2025 earnings released: EPS: AU$0.074 (vs AU$0.099 in 1H 2024)First half 2025 results: EPS: AU$0.074 (down from AU$0.099 in 1H 2024). Revenue: AU$77.5m (up 11% from 1H 2024). Net income: AU$107.2m (down 26% from 1H 2024). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Infrastructure industry in Australia. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.Board Change • Aug 18High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jul 18Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case AppealAtlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year.お知らせ • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.お知らせ • Mar 11Atlas Arteria Limited, Annual General Meeting, May 15, 2025Atlas Arteria Limited, Annual General Meeting, May 15, 2025.お知らせ • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.Board Change • Feb 04High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 24High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Declared Dividend • Sep 21First half dividend of AU$0.20 announcedDividend of AU$0.20 is the same as last year. Ex-date: 24th September 2024 Payment date: 7th October 2024 Dividend yield will be 8.4%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (194% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 116% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.お知らせ • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.Board Change • Sep 10High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Executive Director Danny Elia was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 30First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)First half 2024 results: EPS: AU$0.099 (down from AU$0.12 in 1H 2023). Revenue: AU$69.6m (up 9.6% from 1H 2023). Net income: AU$144.3m (down 14% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Infrastructure industry in Oceania. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Aug 21+ 1 more updateAtlas Arteria Limited Appoints Hugh Wehby as Managing DirectorOn August 21, 2024, Atlas Arteria Limited announced that the Board has appointed Hugh Wehby as the company's new Managing Director. Hugh has extensive experience in the Australian listed infrastructure market, having held executive roles at Transurban and Sydney Airport. Hugh is currently Chief Commercial Officer at Transurban where his core focus is on delivering excellent on- road experience for customers, driving efficiency across all Australian markets and execution of corporate development opportunities. Previous to this role, Hugh was the Group Executive Partners, Delivery and Risk where he had global responsibility for strategic investment partnerships, major project delivery, new project opportunity development, risk, and health, safety, and environment. In North America, Hugh has been a member of Transurban's USA joint venture board since its inception, responsible for the delivery of a multi- billion dollar construction program and charged with identifying and developing growth opportunities. During his time at Transurban, he also drove the successful resolution of a complex dispute surrounding the West Gate Tunnel Project. Prior to Transurban, Hugh spent 10 years with Sydney Airport where he served in a number of roles including Chief Financial Officer and Chief Operating Officer. While COO, Hugh led the Company's initial response to the COVID-19 business disruption, refocused the organisation on safety and performance optimisation, and positioned the airport as a global sustainability leader in the infrastructure sector. Hugh's time in Macquarie Group and MAp Airports saw him based in Europe, where he primarily worked across the UK, Belgium, Denmark and Italy. His focus was on partnering with local senior management teams to drive strategic outcomes, financial growth and value.お知らせ • Jun 18+ 1 more updateAtlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025Atlas Arteria Limited announced that they will report first half, 2025 results on Aug 28, 2025Declared Dividend • Mar 23Final dividend of AU$0.20 announcedDividend of AU$0.20 is the same as last year. Ex-date: 26th March 2024 Payment date: 8th April 2024 Dividend yield will be 7.5%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (132% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 20% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 47% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Mar 22+ 1 more updateAtlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing DirectorAtlas Arteria announced that CEO and Managing Director Graeme Bevans has notified the Boards of his intention to retire. Graeme has agreed that he will stay on until a new CEO and Managing Director has been appointed to ensure an orderly transition to new leadership, consistent with the 12 month notice period in Graeme's employment contract. Since his appointment as CEO and Managing Director in 2018, Graeme has built and led a highly skilled and capable team and instilled a strong, values-led culture across the Group. He has also led a number of major strategic initiatives to significantly unlock value in the portfolio and position the business for sustainable growth. These include restructuring the APRR holding with the buyout of Macquarie andMacquarie Fund investors and renegotiating shareholder arrangements to improve Atlas Arteria's governance arrangements; the restructuring of Warnow Tunnel; and the acquisition of Chicago Skyway. Together, these initiatives have diversified the Company's cash flows, extended average concession life; and positioned the business to take advantage of adjacent opportunities including the expected retendering of the APRR and AREA concessions as they mature in 2035 and 2036, respectively. A global search for Graeme's replacement will be undertaken, and in the interim Graeme will continue to be focussed on delivering the recently articulated strategy of business optimisation, associated growth opportunities and capital management.お知らせ • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.お知らせ • Mar 14Atlas Arteria Limited, Annual General Meeting, May 16, 2024Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)Full year 2023 results: EPS: AU$0.22. Revenue: AU$134.0m (down 4.5% from FY 2022). Net income: AU$323.5m (up 21% from FY 2022). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Infrastructure industry in Oceania.お知らせ • Oct 16Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive DirectorAtlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree.お知らせ • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.Reported Earnings • Sep 01First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)First half 2023 results: EPS: AU$0.12. Revenue: AU$63.5m (up 17% from 1H 2022). Net income: AU$167.6m (up 32% from 1H 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Infrastructure industry in Oceania.お知らせ • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.お知らせ • Jun 14Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024お知らせ • Jun 07Atlas Arteria Limited Appoints Ken Daley as DirectorAtlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023.お知らせ • Jun 01Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023.Reported Earnings • Feb 24Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)Full year 2022 results: EPS: AU$0.25 (up from AU$0.19 in FY 2021). Revenue: AU$140.4m (up 40% from FY 2021). Net income: AU$267.0m (up 46% from FY 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Infrastructure industry in Oceania. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Board Change • Jan 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. MD, CEO & Executive Director Graeme Bevans was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • Nov 04Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be AU$8.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 21% over the last 3 years. Earnings per share has grown by 99%. Revenue is forecast to grow by 226% in 2 years. Earnings is forecast to grow by 126% in the next 2 years.お知らせ • Sep 19+ 1 more updateAtlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023Atlas Arteria Limited announced that they will report Q4, 2022 results on Feb 23, 2023Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to AU$6.71, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 25x in the Infrastructure industry in Oceania. Total loss to shareholders of 3.9% over the past three years.Reported Earnings • Sep 02First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)First half 2022 results: EPS: AU$0. Revenue: AU$54.7m (up 26% from 1H 2021). Net income: AU$127.5m (up 59% from 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 22% growth forecast for the Infrastructure industry in Australia.Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to AU$8.25, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 23x in the Infrastructure industry in Oceania. Total returns to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at AU$6.75 per share.Recent Insider Transactions • Mar 03Independent Non-Executive Director recently bought AU$76k worth of stockOn the 25th of February, Ariane Barker bought around 12k shares on-market at roughly AU$6.59 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$275k more in shares than they have sold in the last 12 months.Reported Earnings • Feb 25Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: AU$0.17 (up from AU$0.017 loss in FY 2020). Revenue: AU$100.7m (down 5.6% from FY 2020). Net income: AU$183.2m (up AU$199.3m from FY 2020). Revenue missed analyst estimates by 4.5%. Over the next year, revenue is forecast to grow 30%, compared to a 25% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Sep 23Insider recently bought AU$67k worth of stockOn the 16th of September, D. Cook bought around 10k shares on-market at roughly AU$6.69 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$338k more in shares than they have sold in the last 12 months.Reported Earnings • Aug 28First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)First half 2021 results: Revenue: AU$43.5m (down 27% from 1H 2020). Net income: AU$80.1m (up AU$174.4m from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Recent Insider Transactions • Mar 03Independent Chairman of the Board recently bought AU$100k worth of stockOn the 1st of March, Debra Goodin bought around 18k shares on-market at roughly AU$5.61 per share. This was the largest purchase by an insider in the last 3 months. Debra has been a buyer over the last 12 months, purchasing a net total of AU$108k worth in shares.Reported Earnings • Feb 26Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: AU$106.7m (down 39% from FY 2019). Net loss: AU$16.1m (down 194% from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 132 percentage points per year, which is a significant difference in performance.Analyst Estimate Surprise Post Earnings • Feb 26Revenue misses expectationsRevenue missed analyst estimates by 6.3%. Over the next year, revenue is forecast to grow 10%, compared to a 5.2% growth forecast for the Infrastructure industry in Australia.Is New 90 Day High Low • Feb 12New 90-day low: AU$6.00The company is down 9.0% from its price of AU$6.63 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Infrastructure industry, which is down 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.17 per share.Is New 90 Day High Low • Oct 29New 90-day low: AU$5.95The company is down 10.0% from its price of AU$6.58 on 31 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Infrastructure industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$13.42 per share.Is New 90 Day High Low • Oct 01New 90-day low: AU$6.10The company is down 8.0% from its price of AU$6.65 on 03 July 2020. The Australian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Infrastructure industry, which is down 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$12.46 per share.業績と収益の成長予測CHIA:ALX - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028181501662217412/31/2027170464592186512/31/2026159411572241512/31/20251602608888N/A9/30/20251572799091N/A6/30/20251542999394N/A3/31/20251503179394N/A12/31/20241463369293N/A9/30/20241433189091N/A6/30/20241403008788N/A3/31/20241373128686N/A12/31/20231343248485N/A9/30/20231313158687N/A6/30/20231283078990N/A3/31/20231232878182N/A12/31/20221182677374N/A9/30/20221152646566N/A6/30/20221112605658N/A3/31/20221062225153N/A12/31/20211011834648N/A9/30/2021961343741N/A6/30/202191852935N/A3/31/202199132937N/A12/31/2020107-602939N/A9/30/2020128-374052N/A6/30/2020149-145264N/A3/31/202016225670N/A12/31/2019175176176N/A9/30/201916717N/A56N/A6/30/201915918N/A35N/A3/31/201914647N/A29N/A12/31/201813277N/A23N/A9/30/201812678N/A34N/A6/30/201812078N/A46N/A3/31/2018101270N/A32N/A12/31/201783462N/A18N/A9/30/201754506N/A-4N/A6/30/201725550N/A-25N/A3/31/201714388N/A-20N/A12/31/20163225N/A-16N/A9/30/20162162N/A-14N/A6/30/2016299N/A-13N/A3/31/2016292N/A-27N/A12/31/2015285N/A-42N/A9/30/2015371N/A-41N/A6/30/2015358N/A-40N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ALXの予測収益成長率 (年間19% ) は 貯蓄率 ( 3.6% ) を上回っています。収益対市場: ALXの収益 ( 19% ) はAustralian市場 ( 12% ) よりも速いペースで成長すると予測されています。高成長収益: ALXの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: ALXの収益 ( 4.9% ) Australian市場 ( 6.4% ) よりも低い成長が予測されています。高い収益成長: ALXの収益 ( 4.9% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ALXの 自己資本利益率 は、3年後には低くなると予測されています ( 6.3 %)。成長企業の発掘7D1Y7D1Y7D1YTransportation 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/09 09:56終値2026/05/08 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Atlas Arteria Limited 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。15 アナリスト機関Matthew RyanBarrenjoey Markets Pty LimitedShaurya VisenBofA Global ResearchSuraj NebhaniCitigroup Inc12 その他のアナリストを表示
Board Change • May 01High number of new directorsCEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024.
お知らせ • Apr 27IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer. The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer. Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited.
お知らせ • Mar 17Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026
お知らせ • Mar 16Atlas Arteria Limited, Annual General Meeting, May 13, 2026Atlas Arteria Limited, Annual General Meeting, May 13, 2026.
Board Change • Dec 24High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 10Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026
Reported Earnings • Aug 29First half 2025 earnings released: EPS: AU$0.074 (vs AU$0.099 in 1H 2024)First half 2025 results: EPS: AU$0.074 (down from AU$0.099 in 1H 2024). Revenue: AU$77.5m (up 11% from 1H 2024). Net income: AU$107.2m (down 26% from 1H 2024). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Infrastructure industry in Australia. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings.
Board Change • Aug 18High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jul 18Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case AppealAtlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year.
お知らせ • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.
お知らせ • Mar 11Atlas Arteria Limited, Annual General Meeting, May 15, 2025Atlas Arteria Limited, Annual General Meeting, May 15, 2025.
お知らせ • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.
Board Change • Feb 04High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 24High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Declared Dividend • Sep 21First half dividend of AU$0.20 announcedDividend of AU$0.20 is the same as last year. Ex-date: 24th September 2024 Payment date: 7th October 2024 Dividend yield will be 8.4%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (194% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 116% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
お知らせ • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.
Board Change • Sep 10High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Executive Director Danny Elia was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 30First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)First half 2024 results: EPS: AU$0.099 (down from AU$0.12 in 1H 2023). Revenue: AU$69.6m (up 9.6% from 1H 2023). Net income: AU$144.3m (down 14% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Infrastructure industry in Oceania. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Aug 21+ 1 more updateAtlas Arteria Limited Appoints Hugh Wehby as Managing DirectorOn August 21, 2024, Atlas Arteria Limited announced that the Board has appointed Hugh Wehby as the company's new Managing Director. Hugh has extensive experience in the Australian listed infrastructure market, having held executive roles at Transurban and Sydney Airport. Hugh is currently Chief Commercial Officer at Transurban where his core focus is on delivering excellent on- road experience for customers, driving efficiency across all Australian markets and execution of corporate development opportunities. Previous to this role, Hugh was the Group Executive Partners, Delivery and Risk where he had global responsibility for strategic investment partnerships, major project delivery, new project opportunity development, risk, and health, safety, and environment. In North America, Hugh has been a member of Transurban's USA joint venture board since its inception, responsible for the delivery of a multi- billion dollar construction program and charged with identifying and developing growth opportunities. During his time at Transurban, he also drove the successful resolution of a complex dispute surrounding the West Gate Tunnel Project. Prior to Transurban, Hugh spent 10 years with Sydney Airport where he served in a number of roles including Chief Financial Officer and Chief Operating Officer. While COO, Hugh led the Company's initial response to the COVID-19 business disruption, refocused the organisation on safety and performance optimisation, and positioned the airport as a global sustainability leader in the infrastructure sector. Hugh's time in Macquarie Group and MAp Airports saw him based in Europe, where he primarily worked across the UK, Belgium, Denmark and Italy. His focus was on partnering with local senior management teams to drive strategic outcomes, financial growth and value.
お知らせ • Jun 18+ 1 more updateAtlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025Atlas Arteria Limited announced that they will report first half, 2025 results on Aug 28, 2025
Declared Dividend • Mar 23Final dividend of AU$0.20 announcedDividend of AU$0.20 is the same as last year. Ex-date: 26th March 2024 Payment date: 8th April 2024 Dividend yield will be 7.5%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (132% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 20% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 47% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Mar 22+ 1 more updateAtlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing DirectorAtlas Arteria announced that CEO and Managing Director Graeme Bevans has notified the Boards of his intention to retire. Graeme has agreed that he will stay on until a new CEO and Managing Director has been appointed to ensure an orderly transition to new leadership, consistent with the 12 month notice period in Graeme's employment contract. Since his appointment as CEO and Managing Director in 2018, Graeme has built and led a highly skilled and capable team and instilled a strong, values-led culture across the Group. He has also led a number of major strategic initiatives to significantly unlock value in the portfolio and position the business for sustainable growth. These include restructuring the APRR holding with the buyout of Macquarie andMacquarie Fund investors and renegotiating shareholder arrangements to improve Atlas Arteria's governance arrangements; the restructuring of Warnow Tunnel; and the acquisition of Chicago Skyway. Together, these initiatives have diversified the Company's cash flows, extended average concession life; and positioned the business to take advantage of adjacent opportunities including the expected retendering of the APRR and AREA concessions as they mature in 2035 and 2036, respectively. A global search for Graeme's replacement will be undertaken, and in the interim Graeme will continue to be focussed on delivering the recently articulated strategy of business optimisation, associated growth opportunities and capital management.
お知らせ • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.
お知らせ • Mar 14Atlas Arteria Limited, Annual General Meeting, May 16, 2024Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)Full year 2023 results: EPS: AU$0.22. Revenue: AU$134.0m (down 4.5% from FY 2022). Net income: AU$323.5m (up 21% from FY 2022). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Infrastructure industry in Oceania.
お知らせ • Oct 16Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive DirectorAtlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree.
お知らせ • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.
Reported Earnings • Sep 01First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)First half 2023 results: EPS: AU$0.12. Revenue: AU$63.5m (up 17% from 1H 2022). Net income: AU$167.6m (up 32% from 1H 2022). Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Infrastructure industry in Oceania.
お知らせ • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.
お知らせ • Jun 14Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024
お知らせ • Jun 07Atlas Arteria Limited Appoints Ken Daley as DirectorAtlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023.
お知らせ • Jun 01Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023.
Reported Earnings • Feb 24Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)Full year 2022 results: EPS: AU$0.25 (up from AU$0.19 in FY 2021). Revenue: AU$140.4m (up 40% from FY 2021). Net income: AU$267.0m (up 46% from FY 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Infrastructure industry in Oceania. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Board Change • Jan 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. MD, CEO & Executive Director Graeme Bevans was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Nov 04Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be AU$8.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 21% over the last 3 years. Earnings per share has grown by 99%. Revenue is forecast to grow by 226% in 2 years. Earnings is forecast to grow by 126% in the next 2 years.
お知らせ • Sep 19+ 1 more updateAtlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023Atlas Arteria Limited announced that they will report Q4, 2022 results on Feb 23, 2023
Valuation Update With 7 Day Price Move • Sep 17Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to AU$6.71, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 25x in the Infrastructure industry in Oceania. Total loss to shareholders of 3.9% over the past three years.
Reported Earnings • Sep 02First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)First half 2022 results: EPS: AU$0. Revenue: AU$54.7m (up 26% from 1H 2021). Net income: AU$127.5m (up 59% from 1H 2021). Over the next year, revenue is forecast to grow 17%, compared to a 22% growth forecast for the Infrastructure industry in Australia.
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to AU$8.25, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 23x in the Infrastructure industry in Oceania. Total returns to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at AU$6.75 per share.
Recent Insider Transactions • Mar 03Independent Non-Executive Director recently bought AU$76k worth of stockOn the 25th of February, Ariane Barker bought around 12k shares on-market at roughly AU$6.59 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$275k more in shares than they have sold in the last 12 months.
Reported Earnings • Feb 25Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: AU$0.17 (up from AU$0.017 loss in FY 2020). Revenue: AU$100.7m (down 5.6% from FY 2020). Net income: AU$183.2m (up AU$199.3m from FY 2020). Revenue missed analyst estimates by 4.5%. Over the next year, revenue is forecast to grow 30%, compared to a 25% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Sep 23Insider recently bought AU$67k worth of stockOn the 16th of September, D. Cook bought around 10k shares on-market at roughly AU$6.69 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$338k more in shares than they have sold in the last 12 months.
Reported Earnings • Aug 28First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)First half 2021 results: Revenue: AU$43.5m (down 27% from 1H 2020). Net income: AU$80.1m (up AU$174.4m from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Recent Insider Transactions • Mar 03Independent Chairman of the Board recently bought AU$100k worth of stockOn the 1st of March, Debra Goodin bought around 18k shares on-market at roughly AU$5.61 per share. This was the largest purchase by an insider in the last 3 months. Debra has been a buyer over the last 12 months, purchasing a net total of AU$108k worth in shares.
Reported Earnings • Feb 26Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: AU$106.7m (down 39% from FY 2019). Net loss: AU$16.1m (down 194% from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 132 percentage points per year, which is a significant difference in performance.
Analyst Estimate Surprise Post Earnings • Feb 26Revenue misses expectationsRevenue missed analyst estimates by 6.3%. Over the next year, revenue is forecast to grow 10%, compared to a 5.2% growth forecast for the Infrastructure industry in Australia.
Is New 90 Day High Low • Feb 12New 90-day low: AU$6.00The company is down 9.0% from its price of AU$6.63 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Infrastructure industry, which is down 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.17 per share.
Is New 90 Day High Low • Oct 29New 90-day low: AU$5.95The company is down 10.0% from its price of AU$6.58 on 31 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Infrastructure industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$13.42 per share.
Is New 90 Day High Low • Oct 01New 90-day low: AU$6.10The company is down 8.0% from its price of AU$6.65 on 03 July 2020. The Australian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Infrastructure industry, which is down 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$12.46 per share.